1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.

Drug Shipments From Indian Company Must Stop Due to Poor The Quality of the Products

  1. Beenthere2Hippie
    OTTAWA - Health Canada has asked an Indian company to voluntarily stop shipment of products to Canada, based on a review of recent manufacturing practices by the U.S. Food and Drug Administration.

    The FDA found falsification and manipulation of data issues at pharmaceutical company IPCA Laboratories, which manufactures more than 350 drug formulations. IPCA has not disputed the FDA findings with Health Canada, which estimates that about 21 active pharmaceutical ingredients are involved.

    The federal department has also asked Canadian companies that import products containing the active ingredients from IPCA facilities to temporarily quarantine the products. To date, there has been no indication that the issues identified by the FDA inspection pose a risk to health, so neither Health Canada nor the FDA has requested a recall of products already on the market.

    Health Canada says it is working with other international regulatory partners, Canadian importers and IPCA to gather more information about affected products. This information includes any additional testing being done, the medical necessity of the products involved, their market share and risk assessments — a process that will likely take a few weeks to complete.

    "At this time, we do not expect that there will be an immediate impact on the availability of these products," a Health Canada advisory said Wednesday. "The department will work with the provinces and territories to monitor the supply situation and, if necessary, develop mitigation strategies."

    Health Canada has requested that the voluntary quarantine continue until it is satisfied that adequate measures are in place to confirm the quality of the products from IPCA facilities. The 60-year-old company's website says its clients include such global pharmaceutical giants as AstraZeneca, GSK, Merck, Roche and Sanofi Aventis.

    By The Canadian Press/September 18, 2014


    Graphic: Urgentcare.com

    Newshawk Crew​

    Author Bio

    BT2H is a retired news editor and writer from the NYC area who, for health reasons, retired to a southern US state early, and where BT2H continues to write and to post drug-related news to DF.


To make a comment simply sign up and become a member!